LFBGroup

LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in major therapeutic areas: immunology, hemostasis, perinatal and intensive care.
Number one in France and 6th in the world for plasma-derived medicinal products, the LFB group is also one of the leading European companies for the development and production of proteins and innovative treatments derived from biotechnologies. 
Relying on its sustained research effort, the LFB group is implementing a growth strategy to expand its activities to international markets.